Henogen S.A. acquires 4C Biotech S.A.

02-Jul-2003

Henogen, located at Charleroi in Belgium, has recently closed the acquisition of 4C Biotech, Seneffe, a Contract Manufacturing Organization dedicated to the development of mammalian cell culture processes for the production of biotherapeutics. This acquisition extends the existing services portfolio of Henogen « from gene to GMP clinical batch production « to the large scale production of monoclonal antibodies and recombinant proteins.

The new 60 people strong company will operate on two GMP sites, with more than 10 BL2/BL3 culture and purification suites equipped with the latest bioreactors up to 300L capacity .

· The site of Charleroi will be dedicated to the Bacteria, yeast, baculovirus and viral vectors productions. · The site of Seneffe will be dedicated to the large scale production of monoclonal antibodies and recombinant proteins thanks to its historical know-how regarding the perfused culture of mammalian cells .

Henogen now offers to the biopharmaceutical community a very complete services portfolio which starts from the molecular biology and the choice of the best expression system up to the sterile filling and the release of phase I/II clinical grade material.

Quite unique in Europe, such an integrated service targets a wide range of customers whether large pharmaceutical companies, innovative drug discovery biotech SME's or health related public institutions.

Other news from the department business & finance

These products might interest you

Biostat STR

Biostat STR by Sartorius

Biostat STR Generation 3 Bioreactors

Engineered for Ultimate Upstream Performance

bioreactors
Ambr® 250 HT Consumables

Ambr® 250 HT Consumables by Sartorius

Efficient bioprocesses with single-use bioreactors

Minimise cleaning effort and maximise flexibility for cell and microbial cultures

bioreactors
Ambr® 250 Modular

Ambr® 250 Modular by Sartorius

Mini bioreactors for cell and gene therapies with high scalability

Maximise your process development with reliable single-use vessels

bioreactors
Brooks Instrument SLA Biotech-Serie

Brooks Instrument SLA Biotech-Serie by Brooks Instrument

Control bioprocesses efficiently and precisely with flow controllers for biotechnology applications

The SLA Biotech series has been developed specifically for the requirements in bioprocesses

mass flow controllers
Flexcell Systems

Flexcell Systems by Dunn

Flexcell Cell Stretching Bioreactors for Life Science Research

Used in over 1300 laboratories worldwide, and cited in over 4000 research publications

bioreactors
SLAMf Biotech-Serie Massendurchflussregler

SLAMf Biotech-Serie Massendurchflussregler by Brooks Instrument

SLAMf Mass Flow Controllers Designed Specifically for Biotech (IP66 / NEMA 4X)

Special equipment for biotech process plants, suitable for splash water and high-pressure cleaning

mass flow controllers
Loading...

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Topic world Antibodies

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous